Michael Lynch is an Innovations & New Technologies Manager at Servier, specializing in identifying next-generation drugs and innovative drug delivery technologies. With a PhD from the University of Strathclyde, Michael has a deep background in analytical and solid-state chemistry, having held various roles at Technologie Servier from 1996 to 2020. In their current position, they lead initiatives to scout and integrate disruptive technologies, aiming to redefine the future of healthcare through collaboration and innovation. Michael also served as a Senior Solid State Scientist at Servier Pharmaceuticals, where they developed optimal solid forms for drug formulations, enhancing their expertise in R&D and production processes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices